PMS Registry
Company Name
Novartis (Taiwan) Co., Ltd.
Protocol Number
Title of Study
Retrospective, non-interventional, multi-center study evaluating safety of fingolimod in patients with multiple sclerosis in Taiwan
Primary Objective
1. To evaluate safety data of patients who had taken fingolimod for the treatment of relapsing-remitting multiple sclerosis (RRMS)
2. To evaluate MS activity of patients treated with fingolimod
Number of Sites
Period of Study
From:Jan. 15, 2016 to:Feb., 2017
Number of Patients
90 (study for Taiwan only)人
IRB Approval Date
Dec. 25, 2015
Publication Plan / Date